Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tam

Showing results (61-70 of 1,070) with videos related to

Pageof 107
Sort By:
Leukemia & Lymphoma|July 27, 2021
Between a rock and a hard place: COVID-19 vaccination and patients on rituximab therapyBenjamin W Teh, Constantine S Tam
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 3, 2023
Cognitive development and the effectiveness of patient educationJonathan S Tam, Jennifer A Hershfield
Blood|March 24, 2006
The infectious consequences of rituximab addition to fludarabine-containing regimensConstantine S Tam, John F Seymour
Leukemia & Lymphoma|July 24, 2018
Vigilance for ibrutinib-associated ventricular arrhythmias: rare but be awareConstantine S Tam, Jennifer R Brown
Leukemia & Lymphoma|June 30, 2009
Autologous and allogeneic stem cell transplantation: rising therapeutic promise for mantle cell lymphomaConstantine S Tam, Issa F Khouri
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2017
Choosing and sequencing novel drugs in CLL: dealing with an embarrassment of riches?C S Tam, J F Seymour
Lupus|October 31, 1998
Successful treatment with immunosuppression, anticoagulation and vasodilator therapy of pulmonary hypertension in SLE associated with secondary antiphospholipid syndromeL S Tam, E K Li
Leukemia & Lymphoma|September 13, 2012
Selection of rituximab dosage in chronic lymphocytic leukemia: where is the evidence?Constantine S Tam, Michael J Keating
Archives of Disease in Childhood|October 1, 1972
Gastric aspirate findings in neonatal pneumoniaC Y Yeung, A S Tam
Blood|May 8, 2023
Pirtobrutinib: a new hope for patients with BTK inhibitor-refractory lymphoproliferative disordersPhilip A Thompson, Constantine S Tam
Pageof 107

Showing results (61-70 of 1,070) with videos related to

Sort By:
Pageof 107
Leukemia & Lymphoma|July 27, 2021
Between a rock and a hard place: COVID-19 vaccination and patients on rituximab therapyBenjamin W Teh, Constantine S Tam
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 3, 2023
Cognitive development and the effectiveness of patient educationJonathan S Tam, Jennifer A Hershfield
Blood|March 24, 2006
The infectious consequences of rituximab addition to fludarabine-containing regimensConstantine S Tam, John F Seymour
Leukemia & Lymphoma|July 24, 2018
Vigilance for ibrutinib-associated ventricular arrhythmias: rare but be awareConstantine S Tam, Jennifer R Brown
Leukemia & Lymphoma|June 30, 2009
Autologous and allogeneic stem cell transplantation: rising therapeutic promise for mantle cell lymphomaConstantine S Tam, Issa F Khouri
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2017
Choosing and sequencing novel drugs in CLL: dealing with an embarrassment of riches?C S Tam, J F Seymour
Lupus|October 31, 1998
Successful treatment with immunosuppression, anticoagulation and vasodilator therapy of pulmonary hypertension in SLE associated with secondary antiphospholipid syndromeL S Tam, E K Li
Leukemia & Lymphoma|September 13, 2012
Selection of rituximab dosage in chronic lymphocytic leukemia: where is the evidence?Constantine S Tam, Michael J Keating
Archives of Disease in Childhood|October 1, 1972
Gastric aspirate findings in neonatal pneumoniaC Y Yeung, A S Tam
Blood|May 8, 2023
Pirtobrutinib: a new hope for patients with BTK inhibitor-refractory lymphoproliferative disordersPhilip A Thompson, Constantine S Tam
Pageof 107